Allogene Therapeutics, Inc. (ALLO)
NASDAQ·Healthcare·Biotechnology
$2.20
-2.05%
Mkt Cap $563.34M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | $2.50K | — | — | -$0.25 | -$0.17 | +32.00% | — | — |
| Q4 2025 Nov 6, 2025 | $1.82K | — | — | -$0.23 | -$0.19 | +17.39% | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | -$0.28 | -$0.23 | +17.86% | — | — |
| Q2 2025 May 13, 2025 | $1.67K | — | — | -$0.28 | -$0.28 | +0.00% | — | — |
| Q1 2025 Mar 13, 2025 | $12.00K | $22.00K | +83.33% | -$0.34 | -$0.28 | +17.65% | — | — |
| Q4 2024 Nov 7, 2024 | $12.11K | — | — | -$0.34 | -$0.27 | +20.59% | — | — |
| Q3 2024 Aug 7, 2024 | $20.00K | — | — | -$0.35 | -$0.32 | +8.57% | — | — |
| Q2 2024 May 13, 2024 | $10.00K | $22.00K | +120.00% | -$0.38 | -$0.38 | +0.00% | — | — |
| Q1 2024 Mar 14, 2024 | $20.00K | $21.00K | +5.00% | -$0.47 | -$0.43 | +8.51% | — | — |
| Q4 2023 Nov 2, 2023 | $20.00K | $43.00K | +115.00% | -$0.53 | -$0.37 | +30.19% | — | — |
| Q3 2023 Aug 2, 2023 | $20.00K | $44.00K | +120.00% | -$0.59 | -$0.53 | +10.17% | — | — |
| Q2 2023 May 3, 2023 | $10.00K | $52.00K | +420.00% | -$0.63 | -$0.68 | -7.94% | — | — |
| Q1 2023 Feb 28, 2023 | $77.18K | $47.00K | -39.10% | -$0.71 | -$0.66 | +7.04% | — | — |
| Q4 2022 Nov 2, 2022 | $7.17K | $49.00K | +583.69% | -$0.62 | -$0.58 | +6.45% | — | — |
| Q3 2022 Aug 9, 2022 | $12.38K | $86.00K | +594.39% | -$0.61 | -$0.52 | +14.75% | — | — |
| Q2 2022 May 4, 2022 | $8.33K | $61.00K | +632.03% | -$0.59 | -$0.56 | +5.08% | — | — |
| Q1 2022 Feb 23, 2022 | $56.10K | $51.00K | -9.09% | -$0.61 | -$0.54 | +11.48% | — | — |
| Q4 2021 Nov 4, 2021 | $10.00K | $49.00K | +390.00% | -$0.56 | -$0.57 | -1.79% | — | — |
| Q3 2021 Aug 4, 2021 | $230.00K | $44.00K | -80.87% | -$0.55 | -$0.53 | +3.64% | — | — |
| Q2 2021 May 5, 2021 | $12.84M | $38.34M | +198.64% | -$0.48 | -$0.25 | +47.92% | — | — |